337
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Late relapse of primary central nervous system lymphoma

, , , , , , , , , , , , , , , , & show all
Pages 475-477 | Received 21 Feb 2016, Accepted 05 Jun 2016, Published online: 10 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jun Watanabe, Manabu Natsumeda, Yu Kanemaru, Masayasu Okada, Makoto Oishi, Akiyoshi Kakita & Yukihiko Fujii. (2019) Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma. Leukemia & Lymphoma 60:14, pages 3587-3589.
Read now

Articles from other publishers (4)

Jiawen Huang & Juan Huang. 2023. Immune Checkpoint Inhibitors - New Insights and Recent Progress. Immune Checkpoint Inhibitors - New Insights and Recent Progress.
Inka Puhakka, Hanne Kuitunen, Pekka Jäkälä, Eila Sonkajärvi, Taina Turpeenniemi-Hujanen, Aino Rönkä, Tuomas Selander, Miika Korhonen & Outi Kuittinen. (2022) Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis. BMC Cancer 22:1.
Crossref
Kaiyan Tao, Xuefeng Wang & Xin Tian. (2021) Relapsed Primary Central Nervous System Lymphoma: Current Advances. Frontiers in Oncology 11.
Crossref
Paul J. BröckelmannHelen GoergenCharlotte KohnhorstBastian von TresckowAlden MocciaJana MarkovaJulia MeissnerAndrea KerkhoffWolf-Dieter LudwigMichael FuchsPeter BorchmannAndreas Engert. (2017) Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials. Journal of Clinical Oncology 35:13, pages 1444-1450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.